Matches in DBpedia 2016-04 for { <http://wikidata.dbpedia.org/resource/Q22079537> ?p ?o }
Showing triples 1 to 32 of
32
with 100 triples per page.
- Q22079537 subject Q8301163.
- Q22079537 subject Q8760194.
- Q22079537 abstract "Naurex Inc. is a pharmaceutical company which is developing the drug candidates rapastinel (GLYX-13) and NRX-1074, NMDA receptor modulators, as novel, next-generation antidepressants.On July 26, 2015, it was announced that Allergan would be acquiring Naurex for $560 million.".
- Q22079537 wikiPageExternalLink www.naurex.com.
- Q22079537 wikiPageWikiLink Q1418791.
- Q22079537 wikiPageWikiLink Q18204530.
- Q22079537 wikiPageWikiLink Q18205913.
- Q22079537 wikiPageWikiLink Q18378831.
- Q22079537 wikiPageWikiLink Q21098923.
- Q22079537 wikiPageWikiLink Q2365493.
- Q22079537 wikiPageWikiLink Q243547.
- Q22079537 wikiPageWikiLink Q414896.
- Q22079537 wikiPageWikiLink Q507443.
- Q22079537 wikiPageWikiLink Q5513673.
- Q22079537 wikiPageWikiLink Q76560.
- Q22079537 wikiPageWikiLink Q8301163.
- Q22079537 wikiPageWikiLink Q8760194.
- Q22079537 wikiPageWikiLink Q906187.
- Q22079537 homepage www.naurex.com.
- Q22079537 name "Naurex Inc.".
- Q22079537 type Organization.
- Q22079537 type Agent.
- Q22079537 type Company.
- Q22079537 type Organisation.
- Q22079537 type Agent.
- Q22079537 type SocialPerson.
- Q22079537 type Thing.
- Q22079537 type Q43229.
- Q22079537 comment "Naurex Inc. is a pharmaceutical company which is developing the drug candidates rapastinel (GLYX-13) and NRX-1074, NMDA receptor modulators, as novel, next-generation antidepressants.On July 26, 2015, it was announced that Allergan would be acquiring Naurex for $560 million.".
- Q22079537 label "Naurex".
- Q22079537 homepage www.naurex.com.
- Q22079537 name "Naurex Inc.".